Lurker Nancy
SEC Form 4 insider trading activity
Lurker Nancy has filed 8 SEC Form 4 filings (11 transaction rows) across 3 companies, including ALKS, COLL, EYPT, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: May 23, 2026.
On the most recent filing, Lurker Nancy is listed as Director at COLLEGIUM PHARMACEUTICAL, INC. Inside the rolling window, Lurker Nancy reported no open-market purchases and 4 open-market sales totaling $313K in COLL and EYPT. The largest disclosed transaction in the window is a sale of 4,500 COLL shares on May 13, 2026, worth $162K.
Companies traded
Other insiders at ALKS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$313K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lurker Nancy made?
Lurker Nancy has filed 8 SEC Form 4 filings (11 transaction rows) across 3 companies, including ALKS, COLL, EYPT since 2025.
Which companies does Lurker Nancy trade?
Lurker Nancy has filed SEC Form 4 disclosures for 3 companies, including ALKS, COLL, EYPT.
When was Lurker Nancy's most recent SEC Form 4 filing?
Lurker Nancy's most recent SEC Form 4 filing on Tracefour is dated May 23, 2026.
What is Lurker Nancy's total buy and sell value in the current window?
Inside the rolling retention window, Lurker Nancy bought $0 and sold $313K based on SEC Form 4 filings.
What was Lurker Nancy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,500 COLL shares on 2026-05-13, worth $162K, per SEC Form 4 filings.